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Background/Aim: To evaluate whether non-closure of the visceral peritoneum after total
abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO) in patients with
uterine corpus carcinoma inﬂuences the volume of the small intestine within the irradiated
volume during adjuvant radiotherapy or late radiation intestinal toxicity.
Materials and methods: A total of 152 patients after TAH + BSO with adjuvant pelvic radio-
therapy were studied. The state of peritonealization was retrospectively evaluated based on
surgical protocols. The volume of irradiated bowels was calculated by CT-based delineation
in  a radiotherapy planning system. The inﬂuence of visceral peritonealization upon the vol-
ume of the small intestine within the irradiated volume and consequent late morbidity was
analyzed.
Results: Visceral peritonealization was not performed in 70 (46%) of 152 studied patients.
The state of peritonealization did not affect the volume of the irradiated small intestine
(p  = 0.14). Mean volume of bowels irradiated in patients with peritonealization was 488 cm3
(range 200–840 cm3, median 469 cm3); mean volume of bowels irradiated in patients with-
out  peritonealization was 456 cm3 (range 254–869 cm3, median 428 cm3). We  did not prove
any signiﬁcant difference between both arms. Nor did we observe any inﬂuence of non-
peritonealization upon late intestinal morbidity (p = 0.34).Conclusion: Non-closure of the visceral peritoneum after hysterectomy for uterine corpus
carcinoma does not increase the volume of the small intestine within the irradiated volume,
intes
land
been thought to be necessary to avoid postoperative ascendingwith no consequent 
©  2011 Greater Po
.  Backgroundntil the last decade of the twentieth century, visceral peri-
onealization after hysterectomy was a standard of care all
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over the world. A closure of the visceral peritoneum has alwaysinfections or adhesion formation with the risk of a consequent
ileus. Several studies argued against this procedure at the turn
of the millennium.1–5,7
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Table 1 – Patient and treatment characteristics.
Age MEAN: 64 years (±8.3 years)
FIGO stage (FIGO
1988)
FIGO IB: 33 (22%) patients
FIGO IC: 64 (42%) patients
FIGO IIA: 12 (8%) patients
FIGO IIB: 24 (16%) patients
FIGO IIIA: 12 (8%) patients
FIGO IIIC: 7 (4%) patients
Histology ENDOMETRIOID: 133 (88%) patients
ADENOAKANTOMA: 11 (7%) patients
CARCINOSARCOMA: 5 (3%) patients
PAPILLARY SEROUS: 2 (1%) patients
CLEAR CELL: 1 (1%) patient
Tumor grade GRADE 1: 26 (17%) patients
GRADE 2: 101 (66%) patients
GRADE 3: 25 (17%) patients
Site of surgery GYNECOL. CENTRE: 80 (53) patients
DISTRICT HOSPITAL: 72 (47%) patients
Radiotherapy dose 50 Gy/25 FRACTIONS: 115 (76%) patients
45 Gy/25 FRACTIONS: 37 (24%) patients
Radiotherapy
technique
CONVENTIONAL: 117 (77%) patients
3D-CONFORMAL: 31 (20%) patients
IMRT: 4 (3%) patients
Values are given as a number (%); or mean ± standard deviation.20  reports of practical oncology a
Prospective randomized trials of hundreds of patients
revealed that peritoneal closure at abdominal hysterectomy
provides no immediate postoperative beneﬁts while unnec-
essarily lengthening surgical time and anesthesia exposure
and increasing blood loss.1,2 Omission of peritoneal closure
seems to be safe, as fever, infection, hemorrhage or revi-
sion are similar to peritonealization.3,4,5 On the contrary, a
signiﬁcantly lower number of postoperative irregular pyelo-
grams was reported in cases without peritoneal closure after
radical hysterectomy.6 Moreover, resumption of bowel func-
tion may take place signiﬁcantly earlier in patients with open
peritoneum,3 without a superior risk of subsequent ileus.4,5
Study of pelvic and periaortic peritonealization in radical
ovarian cancer surgery has showed that leaving the pelvic
and periaortic peritoneum open signiﬁcantly decreases the
adhesion formation.7 As s long-term sequelae, peritoneal
non-closure after hysterectomy can cause an increase in peri-
toneal pelvic ﬂuid, however, its clinical impact is supposedly
insigniﬁcant.8
Referenced studies have suggested that the traditional
practice of visceral peritoneal closure should be abolished
at abdominal hysterectomy. Therefore, at present, a major-
ity of gynecologists omit peritonealization in all patients
undergoing hysterectomy for any reason. Unfortunately, some
patients after total abdominal hysterectomy (TAH) and bilat-
eral salpingo-oophorectomy (BSO) for uterine carcinoma
require adjuvant pelvic radiotherapy. With regard to anatom-
ical alterations, bowels usually ﬁll up the empty space in the
pelvis after radical hysterectomy. If the non-closure of visceral
peritoneum increased the volume of the small intestine within
the pelvis in these patients, a larger volume of the irradiated
small intestine would consecutively lead to increased intesti-
nal toxicity. There has been no study evaluating the inﬂuence
of peritoneal non-closure upon the volume of the small intes-
tine in the pelvis up to the present day.
The purpose of this study is to evaluate the inﬂuence of
non-closure of the visceral peritoneum after TAH and BSO
in patients with uterine carcinoma receiving adjuvant radio-
therapy upon the volume of the small intestine within the
irradiated volume and upon the risk of late radiation intestinal
morbidity enhancement.
2.  Materials  and  methods
2.1.  Patients
A total of 235 Caucasian patients with uterine carcinoma had
adjuvant pelvic radiotherapy between the January 2004 and
December 2009 at the Department of Oncology and Radio-
therapy, University Hospital in Hradec Králové. All patients
underwent TAH with BSO. In 82 patients closure of the peri-
toneum was performed after hysterectomy, while visceral
peritonealization was omitted in 70 patients. The state of peri-
tonealization in other 83 patients was not clearly provable
from the documentation; these patients were excluded from
the study, thus 152 patients were left for statistical evaluation.
In 66 of the studied patients (43%), systematic pelvic lym-
phadenectomy was performed; median number of lymph
nodes resected in these patients was 10 (range 1–36; meanFIGO, International Federation of Gynecology and Obstetrics; IMRT,
intensity modulated radiotherapy.
11). Detailed patient and treatment characteristics are listed
in Tables 1 and 2.
2.2. Small  intestine  delineation
Following TAH with BSO, adjuvant pelvic radiotherapy was
performed in all studied patients. In all patients, the radiation
therapy was performed by a linear accelerator with photons of
6–18 MV energy. Majority of patients were treated by a conven-
tional 4-ﬁeld “box” technique; the other patients were treated
by a 3D-conformal radiotherapy (3D-CRT) using 4-ﬁeld indi-
vidually shaped with a multi-leaf collimator (since 2007) or
7-ﬁeld intensity modulated radiotherapy (IMRT; since 2009).
All patients were treated in a supine position with standard
leg-immobilization. No protocol for bowel preparation was
used before planning.
Radiotherapy treatment planning was based on transversal
CT scans of the whole pelvis; thickness of CT slices was mostly
10 mm (in 141 patients) or 5 mm (in 11 patients). Planning
treatment volume consisted of the proximal vaginal stump;
parametria; presacral, internal, external, and common iliac
lymph nodes with cranial border of radiotherapy ﬁelds at L4/L5
spondylous discus in all patients; with 10 mm safety margins
in all directions.
The contours of the small intestine were delineated within
the whole irradiated volume, as deﬁned by the ICRU 50 (Inter-
national Commission on Radiation Units) recommendation,
by the contouring function of the Eclipse radiotherapy treat-
ment planning system (Eclipse; Varian Medical Systems Inc.,
Palo Alto, USA). Precise contours of the small intestine were
performed in all transversal CT slices; every bowel loop was
delineated separately omitting visceral adipose tissue; the
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Table 2 – Distribution of lymphadenectomy, radiotherapy, and intestinal morbidity in the two groups.
Peritoneal closure (N = 82) Peritoneal non-closure (N = 70)
Lymphadenectomy 30 patients (37%) 36 patients (51%)
Radiotherapy technique
Conventional 4-ﬁeld 68 patients (83%) 48 patients (69%)
3D-conformal 4-ﬁeld 14 patients (17%) 17 patients (24%)
IMRT 0 patients 5 patients (7%)
Dose of radiotherapy
45 Gy in 25 fractions 14 patients (17%) 22  patients (31%)
50 Gy in 25 fractions 68 patients (83%) 48  patients (69%)
Late intestinal morbidity
None observed 60 patients (73%) 56 patients (80%)
Grade 1 21 patients (26%) 9 patients (13%)
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arge intestine and rectum were not included (Fig. 1). All cases
ere delineated by one physician to avoid interpersonal vari-
nces. The volume of the small intestine within the irradiated
olume was calculated in every patient by the automatic func-
ion of the Eclipse contouring system. The inﬂuence of visceral
eritoneal closure upon the volume of the small intestine
ithin the irradiated volume and upon the risk of late intesti-
al morbidity was analyzed as a dichotomous variable.
.3. Statistical  analysis
he normality of data distribution in both arms was con-
rmed by D’Agostino analysis; Fishers F-Test (Two Samples
f Variances) was used to exclude unequal variances in both
rms. The inﬂuence of visceral peritonealization upon the
olume of irradiated small intestine was calculated by the
npaired t-Test (Two Sample Assuming Equal Variances). The
ull hypothesis assumed no difference in irradiated bowel vol-
mes in both arms. The predictive factors of peritonealization,
ymphadenectomy, site of surgery, radiotherapy technique,
ose, and age for the volume of irradiated bowels were eval-
ated using a multiple regression analysis. Late intestinal
dverse effects were retrospectively evaluated and classiﬁed
ccording to the RTOG/EORTC late radiation morbidity scor-
ng scheme. The predictive value of peritonealization for late
Fig. 1 – Small intestine delineation.5 patients (7%)
intestinal morbidity was evaluated by logistic regression anal-
ysis. We considered p < 0.05 to be statistically signiﬁcant. All
statistical analyses were performed using the NCSS 2004 sta-
tistical software (NCSS, Keysville, Utah, USA).
3.  Results
The state of peritonealization was provable overall in 152
(65%) patients. Visceral peritonealization after hysterectomy
was performed in 82 (54%) of these patients; while in the
other 70 (46%) patients closure of the visceral peritoneum was
omitted. Mean volume of bowels irradiated by adjuvant radio-
therapy was 473 cm3 (range 200–869 cm3, median 450 cm3).
The state of peritonealization did not affect the volume of
the irradiated small intestine (p = 0.14). Mean volume of bow-
els irradiated in patients with peritonealization was 488 cm3
(range 200–840 cm3, median 469 cm3); mean volume of bowels
irradiated in patients with peritoneal non-closure was 456 cm3
(range 254–869 cm3, median 428 cm3). We did not prove any
signiﬁcant difference between both arms.
No statistically signiﬁcant difference was found in the pre-
dictive value of peritonealization (p = 0.42), lymphadenectomy,
site of surgery, radiotherapy technique, dose, or age for the
volume of irradiated bowel in the multiple regression analysis.
The probability of peritonealization was signiﬁcantly
higher when the surgery was performed in smaller district
departments rather than in our gynecological centre (p = 0.003;
Chi-square test), as it was done in 67% (48/72) patients in
district hospitals and in 43% (34/80) patients in our gyneco-
logical centre. Moreover, there was a signiﬁcant decrease in
the number of peritonealizations with accruing years (p = 0.02;
Chi-square test).
Late intestinal morbidity was observed in 36 patients (24%):
only of grade 1 in 30 patients or grade 2 in 6 patients (Table 2).
Grade 1 toxicity consisted mostly of mild diarrhea or bowel
cramping; grade 2 morbidity was predominantly moderate
diarrhea or colics. The median follow-up for late morbid-
ity evaluation was 40 months; eight patients were lost to
follow-up. Logistic regression analysis showed signiﬁcant pre-
dictive value of irradiated bowel volume upon the risk of late
intestinal morbidity (p = 0.013; OR = 1.003, 95%CI 1.001–1.006);
whereas there was no predictive value of the state of peri-
tonealization (p = 0.34; OR = 1.467, 95%CI 0.684–3.144).
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4.  Discussion
In the present study, we did not prove any inﬂuence of non-
closure of the visceral peritoneum after hysterectomy upon
the volume of the small intestine irradiated by adjuvant radio-
therapy. This ﬁnding supports the common practice whereby
omission of peritonealization after hysterectomy for malig-
nant disease is considered to be safe even in the case of
adjuvant radiotherapy. On the contrary, closure of the visceral
peritoneum can increase the risk of bowel adhesion forma-
tion, as reported by Kadanali et al.7 Bowel loop adhesion in the
small pelvis is a major problem in adjuvant pelvic radiother-
apy, since it causes the application of great doses to the ﬁxated
loop with consequent morbidity. Again, this idea supports the
practice of non-closure of the peritoneum after hysterectomy.
Unfortunately, we  were not able to study all 235 patients
treated at our department in this period. This deﬁciency was
caused by retrospective evaluation, as only accessible data
from surgical protocols could answer the question whether
the peritonealization was performed or omitted. In 83 patients
the surgical protocols could not answer this question. That is
quite a big loss, and a theme for retrospect.
Acute gastrointestinal toxicity, especially acute diarrhea, is
the most common adverse event of adjuvant pelvic radiother-
apy in gynecological malignancies. Acute diarrhea is rarely
the reason for treatment interruption or termination. Intesti-
nal adverse events are directly proportional to the volume
of bowels irradiated,9 hence we can deduce that surgical
techniques which may enlarge the volume of the small intes-
tine within radiation ﬁelds may cause greater post radiation
morbidity.
It seems that non-closure of the pelvic peritoneum is
not that case; however, the clinical impact of our observa-
tion is not clear, as we have no reliable data about patients’
acute gastrointestinal toxicity (retrospective evaluation; not-
standardized acute toxicity questionnaire).
In our study, we found no inﬂuence of the state of visceral
peritonealization upon the risk of late intestinal toxicity after
pelvic radiotherapy. Nonetheless, grade 2 intestinal morbidity
was slightly more  frequent in patients without peritonealiza-
tion. On the other hand, we found a signiﬁcant predictive value
of irradiated bowel volume upon late morbidity, as we had
expected from the Quantec data.9 Once again, there seems to
be no hazard related to peritoneal non-closure in patients with
tumors of the uterus who may require postoperative whole
pelvic radiotherapy.
Finally, we  discovered that the probability of peritoneal-
ization was signiﬁcantly lower for surgeries performed in
our gynecological centre rather than district hospitals. More-
over, there was a signiﬁcant decrease in the number of
peritonealizations with accruing years as well, with no peri-
tonealizations performed in the year 2009 (12 patients studied
that year). These data show the convincing tendency in mod-
ern surgical techniques to leave the peritoneum open.
In the last few years, several randomized trials in early
endometrial carcinoma raised some doubt about the value of
external beam radiotherapy in this setting.10–15 The experi-
ence from our study may therefore seem less important in the
current era. Nevertheless, we hope our ﬁndings can providediotherapy 1 7 ( 2 0 1 2 ) 19–23
a sufﬁcient evidence and consequently moderate potential
uncertainty for surgeons or radiation oncologists.
5.  Conclusion
Non-closure of the visceral peritoneum after abdominal hys-
terectomy and BSO in patients with uterine corpus carcinoma
receiving adjuvant radiotherapy does not increase the volume
of the small intestine within the irradiated volume. Likewise,
there is no consequent intestinal morbidity enhancement in
these patients.
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